Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTouchstar Plc Regulatory News (TST)

Share Price Information for Touchstar Plc (TST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 87.50
Bid: 85.00
Ask: 90.00
Change: 0.00 (0.00%)
Spread: 5.00 (5.882%)
Open: 87.50
High: 87.50
Low: 87.50
Prev. Close: 87.50
TST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

2 Sep 2010 07:00

RNS Number : 0023S
Belgravium Technologies PLC
02 September 2010
 



For Immediate Release

2 September 2010

 

 

 

Belgravium Technologies plc

Interim Results for the Six Months ended 30 June 2010

 

The Board of Belgravium Technologies plc ('Belgravium' or 'the Group'), designers and manufacturers of real-time data capture systems, is pleased to announce Interim results for the six months ended 30 June 2010.

 

Key Financials:

 

30 June 2010

30 June 2009

·; Turnover

£3,657,000

£4,286,000

·; Profit before tax

£26,000

£140,000

·; Basic earnings per share

0.03p

0.11p

 

 

Highlights:

 

·; Progress made on strategy for restoration of profit growth

·; Improvement in sales expected from second half onwards

·; Contract worth £3m over next 30 months will benefit full year outcome

 

Commenting on the interim results, John Kembery, Chairman of Belgravium, said:

 

"The first half saw a continuation of previously announced trends in our business, namely a subdued level of order intake as customers' financial concerns weighed on capital expenditure decisions. We nonetheless believe that our strategy for managing the business through the downturn has proved successful and look forward to an improvement in sales from the second half".

 

For further information please contact:

 

Belgravium Technologies Plc

John Kembery: 07770 731021

KPMG Corporate Finance - Nominated Adviser

Christian Mayo: 0113 231 3000

WH Ireland

Jessica Metcalf (Corporate Broking): 0113 3946623

 

KPMG Corporate Finance, a division of KPMG LLP which is authorised and regulated by the Financial Services Authority for investment business activities, is acting for the Company as nominated adviser in relation to the matters set out in this announcement and is not acting for any other person in relation to these matters. KPMG Corporate Finance will not be responsible to anyone other than Company for providing the protections afforded to its clients or for providing advice in relation to the contents of this announcement.

 

 

 

 

 

 

Chairman's Statement

 

Interim 2010

 

RESULTS

 

Delays in confirming contracts due to financial uncertainty in the market place continued to be a problem in the first half of 2010, with the result that some anticipated orders did not mature until the period closed. Sales for the first half of 2010 were down 15% at £3,657,000 compared to £4,286,000 in the first half of 2009. Whilst margins were improved, profit before tax was affected by the low sales falling to £26,000 compared to £140,000 in 2009.

 

Basic earnings per share were 0.03p per share compared to 0.11p per share in 2009.

 

Orders gained at the end of the period however, mean that sales and profits should be restored in the second half and that Belgravium is well positioned to achieve its strategic objectives.

 

THE MARKET

 

Belgravium manufactures and installs complete systems incorporating both hardware and software for real time data capture in the logistics, petrochemical and mobile retailing markets. Such systems improve efficiency and operating costs and their need is well established and accepted by our customers. Since 2007, however, financial constraints have produced a marked reluctance to commit to capital projects. The process of converting an enquiry from operational management into a financially authorised contract used to take weeks and now takes months, sometimes longer. Upgrades and renewals are equally difficult and whilst there is still an underlying international demand, the market has been frustratingly slow and difficult to forecast. Belgravium's reputation for quality products remains high whilst many competitors have reduced their offering to meet financial constraints.

OPERATIONAL REVIEW

 

Challenging market conditions remained in force for the majority of the first half of 2010 but late in the period, we gained a major contract for the supply of petrochemical systems in Europe which we anticipate will be worth £3 million sales of hardware and software over the next two and a half years. Sufficient of this order is to be delivered in the second half of 2010 to restore sales and profits for the year and will be further supplemented by some smaller orders received recently. Whilst the logistics market remains difficult there has been a lot of activity in mobile retailing and strategic advances in the area should generate some good opportunities over the next year. It would be dangerous to conclude that we have reached the expected turning point in the market but it would appear that our strategy to deal with the recession is working and that we can now anticipate sustained improvements in sales.

 

STRATEGY

 

A five point strategy for restoration of profit growth was outlined in the 2009 annual report. We have made progress as follows:

 

1. Sales focus.

 

We have maintained a determined and persistent sales presence. We have pursued new sectors, widened our product offering and never lost sight of the objective. It has been hard work but we have won new orders and customers.

 

2. Ensuring that products are fit for purpose and the customers stated requirement.

 

This has been the main thrust of our development effort over the past year. Since the 'Boston' was launched we have sought to develop and improve existing products rather than bring in new designs for which there was no immediate demand.

 

3. Supply the complete solution with increasing repeat revenue.

 

This policy remains in force with the aim of improving our margins and the visibility of earnings through repeat business.

 

4. Controlling costs.

 

Numbers employed have fallen slightly through natural wastage. Particularly in the technical area, this has produced operational strain and must be reviewed as and when sales pick up.

 

5. Seek strategic partnerships in areas where we lack specific expertise:

 

This has proved particularly important in mobile retailing where airlines have been seeking an in-flight "chip and pin" device. It is a very specialised area in which we have developed a relationship with Ingenico, Europe's leading chip and pin hardware suppliers. Together with our own new software products and arrangements to reduce the initial capital cost of a system, we now have products to re-awaken interest in this strained market. This policy should bring in some important new contracts over the next year.

 

BALANCE SHEET

 

Despite the reduced turnover, cash generation has remained strong and we have continued to pay off the Bank term loan as quickly as possible. For this reason we are unable to pay an interim dividend in 2010 but it remains the Board's policy to restore dividends as soon as conditions permit.

 

OUTLOOK

 

There is still no general restoration of the international market for Belgravium's products but sales won towards the end of the first half of the year mean that prospects are better for the year as a whole. It is expected that this outlook will be sustained into 2011.

 

Over the longer term, the identification of suitable acquisition opportunities remains an important part of our growth strategy. We seek primarily software businesses which would increase our sectoral coverage gaining entry into new markets. Since such businesses are notoriously difficult to find, we have re-opened the search to be ready when conditions allow.

 

 

 

Consolidated income statement

for the six months ended 30 June 2010

 

 

 

 

 

 

 

 

 

Notes

6 months to

30 June 2010

Total

(Unaudited)

£'000

6 months to

30 June 2009

Total

(Unaudited)

£'000

 

Revenue

 

3,657

 

4,286

 

Operating profit

 

56

 

182

 

Finance costs

 

(30)

 

(42)

 

Profit before tax

 

26

 

140

 

Income tax expense

 

 

-

 

(33)

Profit for the period attributable to equity shareholders

26

107

 

Basic earnings per ordinary share (pence)

 

2

 

0.03

 

0.11

 

Diluted earnings per ordinary share (pence)

 

2

 

0.03

 

0.11

 

 

Consolidated statement of changes in equity

for the six months ended 30 June 2010

Called up share capital

 

(Unaudited)

£'000

 

Share premium account (Unaudited) £'000

Capital redemption reserve (Unaudited) £'000

Profit and loss account

 

(Unaudited)

£'000

Total

 

 

(Unaudited)

£'000

At 30 June 2009

 

5,047

2,932

2,100

(771)

9,308

Profit

 

-

-

-

330

330

At 31 December 2009

 

5,047

2,932

2,100

(441)

9,638

Profit

 

-

-

-

26

26

At 30 June 2010

5,047

2,932

2,100

(415)

9,664

 

 

Consolidated balance sheet

at 30 June 2010

As at

30 June 2010 (Unaudited)

£'000

As at

30 June 2009 (Unaudited)

£'000

At at

31 December 2009 (Audited)

£'000

 

 

Non-current assets

Intangible Assets

Goodwill

9,124

9,124

9,124

Other intangible assets

294

280

298

Property, plant and equipment

275

378

316

9,693

9,782

9,738

Current assets

Inventories

1,317

1,443

1,223

Trade and other receivables

1,581

2,076

2,527

Current tax asset

39

-

50

Cash and cash equivalents

161

3

2

3,098

3,522

3,802

Total assets

12,791

13,304

13,540

Current liabilities

Trade and other payables

2,199

2,197

2,420

Current corporation tax liabilities

-

67

-

Deferred income tax liabilities

39

21

39

Financial liabilities:

Borrowings

 

523

 

814

 

815

Short term provisions

 

17

26

17

2,778

3,125

3,291

 

Non current liabilities

Financial liabilities:

Borrowings

 

 

349

 

871

 

611

Total liabilities

3,127

3,996

3,902

 

Capital and reserves attributable to equity holders of the company

Ordinary shares

5,047

5,047

5,047

Share premium reserve

2,932

2,932

2,932

Capital redemption reserve

2,100

2,100

2,100

Profit and loss account

 

(415)

(771)

(441)

Total equity

9,664

9,308

9,638

Total equity and liabilities

12,791

13,304

13,540

 

 

Consolidated statements of cash flow

For 6 months to 30 June 2010

6 months to

 30 June 2010 (Unaudited) £'000

6 months to

 30 June 2009 (Unaudited) £'000

Cash flows from operating activities

 

Operating profit

56

182

Depreciation

74

89

Amortisation

67

69

Movement in:

Inventories

(94)

(85)

Trade and other receivables

946

571

Trade and other payables

(221)

(619)

Cash generated from operations

 

828

207

Interest paid

(30)

(44)

Corporation tax received

11

-

Net cash generated from operating activities

 

809

163

Cash flows from investing activities

 

Expenditure on intangible fixed assets

(63)

(64)

Purchase of property, plant and equipment

 

(33)

(113)

Net cash used in investing activities

(96)

(177)

 

Cash flows from financing activities

 

Repayment of bank borrowings

(195)

 

(81)

Net cash used in financing activities

(195)

(81)

 

Net increase/(decrease) in cash and cash equivalents

 

 

518

 

(95)

Cash, cash equivalents and bank overdrafts at the beginning of the period

 

(357)

(460)

Cash, cash equivalents and bank overdrafts at the end of the period

161

(555)

 

 

Notes to the interim report

For 6 months to 30 June 2010

 

1.

 

This financial information comprises the condensed consolidated interim balance sheet as at 30 June 2010 and 30 June 2009 and related consolidated interim statement of income and cash flows for the six months then ended of Belgravium Technologies plc (hereinafter referred to as 'financial information'). Belgravium Technologies plc is listed on the Alternative Investment Market. This financial information for the half year ended 30 June 2010 is unaudited and does not comprise statutory accounts within the meaning of section 434 of the Companies Act 2006. This financial information was approved by the Board on 1 September 2010.

 

This financial information has been prepared in accordance with pronouncements on interim reporting issued by the ASB, AIM rule 18 and the accounting policies set out in the 2009 annual report and financial statements which are prepared in accordance with IFRS as adopted by the European Union. The Group has chosen not to adopt IAS 34 'Interim financial statements' in preparing this financial information. This financial information has been prepared under the historical cost convention.

 

The audited accounts for the year ended 31 December 2009 upon which the auditors issued an unqualified opinion, have been delivered to the Registrar of Companies. The audit report on the 2009 accounts did not contain an emphasis of matter paragraph and did not contain a statement made under section 498 of the Companies Act 2006.

 

2.

Earnings per ordinary share

2010

(Unaudited)

£

2009

(Unaudited)

£

 

Basic earnings per ordinary share

 

 0.03p

 

0.11p

Diluted earnings per ordinary share

 

0.03p

0.11p

 

Basic earnings per share is calculated by dividing the earnings attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.

 

For diluted earnings per share the weighted average number of ordinary shares in issue is adjusted to assume conversion of all dilutive ordinary shares. The dilutive ordinary shares represent the share options and warrants granted to employees where the exercise price is less than the average market price of the Company's ordinary shares during the period.

 

2010

(Unaudited)

2009

(Unaudited)

 

Earnings

£'000

Weighted average number of shares

(in thousands)

 

Earnings

£'000

Weighted

average number of shares (in thousands)

Basic EPS

Earnings attributable to ordinary shareholders

26

100,937

107

100,937

Effect of dilutive securities

Options

-

-

-

-

 

Diluted EPS

Adjusted earnings

26

100,937

107

100,937

 

3.

 

The Company did not declare any dividends in the half year ended 30 June 2010.

 

4.

Copies of this statement be will be made available to the public at the Company's office:- 2 Campus Road, Listerhills Science Park, Bradford, West Yorkshire, BD7 1HR, or can be obtained from our website at www.belgravium-IR.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SSWFIFFSSEFU
Date   Source Headline
30th Apr 202412:51 pmRNSAnnual Report & Notice of Annual General Meeting
17th Apr 20247:00 amRNSFinal Results
11th Mar 20247:00 amRNSTrading Update
16th Jan 20249:16 amRNSGrant of options
13th Dec 20237:00 amRNSDirector Appointment
9th Nov 202311:14 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20237:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Sep 20231:29 pmRNSInterim Results Correction
7th Sep 20237:00 amRNSInterim results
4th Aug 202311:25 amRNSHolding(s) in Company
4th Aug 20239:53 amRNSHolding(s) in Company
4th Aug 20237:00 amRNSDirector Dealing
3rd Aug 20233:36 pmRNSTransaction in Own Shares & TVR
31st Jul 20239:59 amRNSHolding(s) in Company
31st Jul 20239:55 amRNSHolding(s) in Company
21st Jun 20237:00 amRNSDividend Policy and Share Buy-Backs
22nd May 20232:54 pmRNSResult of AGM
26th Apr 20237:00 amRNSCapital Reduction
18th Apr 20237:00 amRNSFinal Results
23rd Jan 20237:00 amRNSTrading Update
8th Nov 20227:00 amRNSContract Award
3rd Oct 20229:28 amRNSGrant of options
15th Sep 20227:00 amRNSInterim Results
12th Aug 20229:12 amRNSHolding(s) in Company
26th Jul 20228:02 amRNSTrading Update
20th Jun 20223:00 pmRNSResult of AGM
26th Apr 20227:00 amRNSFinal Results
24th Jan 20227:00 amRNSFull Year Trading Update
20th Oct 202112:25 pmRNSHolding(s) in Company
13th Sep 20217:00 amRNSInterim Results
23rd Jun 20211:53 pmRNSResult of AGM
23rd Jun 20217:00 amRNSAGM Statement
18th Jun 20211:00 pmRNSAGM Update
29th Apr 20214:42 pmRNSSecond Price Monitoring Extn
29th Apr 20214:39 pmRNSPrice Monitoring Extension
22nd Apr 20217:00 amRNSPreliminary Results
13th Jan 20217:00 amRNSTrading Update
7th Sep 20207:00 amRNSInterim Results
30th Jun 202011:09 amRNSResult of AGM
30th Jun 20207:00 amRNSAGM Statement
28th May 20207:00 amRNSFinal Results
1st Apr 20207:00 amRNSUpdate on trading and impact of Coronavirus
26th Feb 20203:07 pmRNSHolding(s) in Company
13th Feb 20208:25 amRNSHolding(s) in Company
5th Feb 20207:00 amRNSTrading Update
28th Jan 202010:57 amRNSHolding(s) in Company
23rd Jan 20201:45 pmRNSHolding(s) in Company
20th Dec 20199:12 amRNSDirector/PDMR Shareholding
18th Dec 20197:00 amRNSTrading Statement
10th Sep 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.